Our platform addresses fundamental
questions about human aging:
who lives long, who lives well, and why?
We focus on diseases of metabolic aging, leading causes of morbidity & mortality
Worldwide
Worldwide
2B
Suffer from cardiometabolic disease (e.g., obesity, T2D, CV disease)
988M
Live with obesity
Risk of death from major diseases
We know there are many pathways that impact human lifespan and healthspan
It is our mission to find them
Key features of our discovery platform:
- Longitudinal omics coupled with serial functional assessments allowing modeling of aging-related progressive physical, cognitive, functional decline
- Healthspan trajectories captured by starting with healthy individuals
Our data-first approach
to metabolic aging
Our unbiased approach identifies translational drug targets spanning novel and known biology
Untracked wilds
Known hallmarks of aging
Differentiated R&D capabilities
-
![]()
Target ID
Bespoke data science ecosystem with AI and ML-enabled insights from our human aging cohorts
-
![]()
Target validation
In-house translational aging core in naturally aged mice
-
![]()
Discovery & development
Expertise across discovery and development with a tech-forward approach
